This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: **Wengsheng Yu: Innovator in HIV Research**
Introduction
Wengsheng Yu, an accomplished inventor based in Edison, NJ, has made significant strides in the field of medical research. With a focus on combating HIV infection, his work has the potential to transform therapeutic approaches for affected individuals.
Latest Patents
Wengsheng Yu holds a notable patent titled "Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection." This patent encompasses Compounds of Formula I and their pharmaceutically acceptable salts or prodrugs. The invention also outlines various compositions incorporating these compounds and methods for their application in treating or preventing HIV infection in subjects.
Career Highlights
Wengsheng Yu is associated with Merck Sharp & Dohme Corporation, a leading global pharmaceutical company renowned for its dedication to improving health through innovative medicines. His work within the company highlights his commitment to advancing scientific discoveries that address critical health challenges.
Collaborations
While specific collaborations have not been detailed, the nature of Wengsheng Yu's work at Merck Sharp & Dohme Corporation likely involves partnerships with other researchers and institutions, broadening the impact of his contributions in the pharmaceutical industry.
Conclusion
Wengsheng Yu's innovative approach to HIV treatment demonstrates the significant role that inventors play in the healthcare sector. His patent on inhibitors of histone deacetylase showcases not only his ingenuity but also the potential for such inventions to transform lives. As the fight against HIV continues, Wengsheng Yu's contributions stand out as a beacon of hope for future advancements in medical therapies.